FEMASYS INC (FEMY): Price and Financial Metrics
FEMY Price/Volume Stats
| Current price | $0.80 | 52-week high | $1.80 |
| Prev. close | $0.80 | 52-week low | $0.69 |
| Day low | $0.79 | Volume | 288,200 |
| Day high | $0.83 | Avg. volume | 359,152 |
| 50-day MA | $1.12 | Dividend yield | N/A |
| 200-day MA | $1.19 | Market Cap | 21.79M |
FEMY Stock Price Chart Interactive Chart >
FEMASYS INC (FEMY) Company Bio
Femasys Inc., a biomedical company, researches, develops, and manufactures medical devices for the women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a sterile, single-use disposable endocervical curettage product; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.
FEMY Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
FEMY Price Returns
| 1-mo | -29.82% |
| 3-mo | -46.67% |
| 6-mo | -28.57% |
| 1-year | -23.81% |
| 3-year | -50.62% |
| 5-year | N/A |
| YTD | -27.27% |
| 2024 | 12.82% |
| 2023 | 8.33% |
| 2022 | -76.92% |
| 2021 | N/A |
| 2020 | N/A |